PTC Therapeutics | PTCT - الربح قبل الضريبة

سعر السهم
71.47
التغيير اليومي
-1.25 -1.72%
شهريا
-0.32%
سنويا
55.34%
Q2 التوقعات
70.03




الربح قبل الضريبة تغيير تاريخ
Acadia Pharmaceuticals USD 3.98M 22.34M 2026-03
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
Amgen USD 1.51B 2.41B 2025-12
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
Biogen USD 377.7M 433.7M 2026-03
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Cytokinetics USD -206.03M 23M 2026-03
Daiichi Sankyo JPY 106.73B 48.96B 2025-12
Enanta Pharmaceuticals USD -22.71M 95.08M 2024-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
Incyte USD 343.6M 46.34M 2026-03
Ionis Pharmaceuticals USD -93M 135M 2026-03
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Novartis USD 3.84B 802M 2026-03
Pfizer USD 5.18B 6.82B 2026-03
PTC Therapeutics USD -2.46M 136.62M 2026-03
Puma Biotechnology USD 20.61M 24.76M 2024-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
TG Therapeutics USD 20.36M 24.73M 2026-03
Ultragenyx Pharmaceutical USD -184M 56M 2026-03
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03
Xencor USD -128.64M 124.37M 2026-03